Dr. Liana Moussatos, Ph.D., Vice President, Equity Research, Emerging Pharmaceuticals, joined Wedbush Morgan Securities, Inc., from Pacific Growth Equities, where she was a Senior Research Analyst. Prior to that she came from UBS Global Asset Management, where she was Director and Portfolio Manager of the UBS Global Biotech Funds for about five years. Previously, Dr. Moussatos was with Bristol-Myers Squibb, where she was a Manager in University and Government Licensing, External Science and Technology, and she also worked with Sloan-Kettering Cancer Institute in the Office of Industrial Affairs and the National Cancer Institute in the Office of Technology Development. Dr. Moussatos received her B.S. in Entomology, and her M.S. in zoology and biochemistry from Clemson University. She received her Ph.D. in plant pathology from the University of California, Davis, and completed a postdoctoral research fellowship in cellular and molecular physiology at the Yale School of Medicine.
